Myriad Genetics has seen its price target nudged higher even as the core fair value estimate stays flat at about $8.52 per share, reflecting a cautious acknowledgment of recent operational progress.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

One of the most detailed 3D maps of how the human chromosomes are organized and folded within a cell's nucleus is published ...

Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially ...

Discover why iShares Core Dividend Growth ETF (DGRO) is a strong buy for consistent dividend growth. Click here to read my ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...

Isabella Strahan is celebrating new growth in many ways. A year after she was declared cancer-free, the 21-year-old shared how her naturally curly, auburn hair changed since it returned post ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors," that control how those genes are read. The findings, published in ...

New research has revealed that a single session of weight training can help fight breast cancer. Researchers at Edith Cowan University in Australia investigated how resistance training and ...

Exercising muscles pumps out substances that can suppress the growth of breast cancer cells, according to an important study of exercise and cancer. The study, published last month, involved 32 women ...